This invention relates to the use of certain 2-amino-2-fluoromethyl-3-(substituted)phenyl propionic acids and derivatives thereof, which are irreversible inhibitors in vivo of aromatic amino acid decarboxylase (AADC) for depleting endogenous monoamines in the central nervous system (CNS) in the